Loading clinical trials...
Loading clinical trials...
Becotatug Vedotin Combined With Sintilimab and Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma：A Multicenter, Randomized, Controlled, Phase 3 Trial
Conditions
Interventions
Becotatug Vedotin
Sintilimab
+4 more
Locations
1
China
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Start Date
March 5, 2026
Primary Completion Date
April 1, 2030
Completion Date
April 1, 2032
Last Updated
March 16, 2026
NCT07340515
NCT06982300
NCT07085988
NCT07072143
NCT06870435
NCT07088861
Lead Sponsor
First Affiliated Hospital of Guangxi Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions